David Casso

4.5k citations
17 papers · 3.9k indexed · 1 hit paper · h-index 14

David Casso

17 papers receiving 3.8k citations

Hit Papers

p21 is a universal inhibitor of cyclin kinases2.9k199320262004201550010001.5k2.0k2.5k

Peers

David Casso
Comparison fields: 5 of 110
  • Oncology 2.2k
  • Biotechnology 381
  • Molecular Biology 2.8k
  • Cancer Research 516
  • Cell Biology 510
Replace Masako Ikeda with:
Masako Ikeda Japan
Chunying Yang United States
Toshinori Ozaki Japan
Francesca Bernassola Italy
Nathalie Rivard Canada
Hayla K. Sluss United States
Pierre P. Roger Belgium
Peter E. Shaw United Kingdom
Youngkyu Park South Korea
Sheldon Rowan United States
David Casso relative to Masako Ikeda Japan Masako Ikeda's profile →
Citations per field
00.5×1.5×
Masako Ikeda · 1×
Citations per year

Countries citing papers authored by David Casso

Since Specialization
Citations

This map shows the geographic impact of David Casso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Casso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Casso more than expected).

Fields of papers citing papers by David Casso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Casso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Casso. The network helps show where David Casso may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Casso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Casso Line = papers co-authored together David Casso links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20124
2 201016
3 200818
4 200616
5 200542
6 2000106
7 200039
8 1999158
9 199664
10 199612
11 199434
12 1994121
13
p21 is a universal inhibitor of cyclin kinasesbreakdown →
19932942
14 199226
15 199270
16 1990225
17
Regulation of adenosine transport by acute and chronic ethanol exposure
19891

About David Casso

David Casso is a scholar working on Physiology, Biotechnology and Oncology, having authored 17 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Hedgehog Signaling Pathway Studies (4 papers), Developmental Biology and Gene Regulation (4 papers), Cancer Research and Treatments (3 papers), Ubiquitin and proteasome pathways (3 papers), Genomics and Chromatin Dynamics (3 papers), Adenosine and Purinergic Signaling (2 papers) and Chromosomal and Genetic Variations (2 papers). The work is most often cited by research in Oncology (2.2k citations), Biotechnology (381 citations) and Molecular Biology (2.8k citations). David Casso has collaborated with scholars based in United States and Switzerland. Frequent co-authors include David Beach, Gregory J. Hannon, Ryûji Kobayashi, Yue Xiong, Hui Zhang, Thomas B. Kornberg, Felipe-Andrés Ramı́rez-Weber, Christopher C. Franklin, Adrienne S. Gordon and I Diamond. Their work appears in journals such as Genetics, Mechanisms of Development, Journal of Biological Chemistry, Molecular and Cellular Biology and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026